MEDIVATION, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 31 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-12-04: Reporting owner King Michael L; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-10-01: Reporting owner Hirmand Mohammad; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2015-10-01: Reporting owner Hirmand Mohammad; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2015-10-01: Reporting owner Hirmand Mohammad; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-12-04 | King Michael L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,235 12,235 owned after | $42.77 exercise price | 2015-12-08 | |
| 2015-10-01 holding as of filing | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.00 exercise price | 2015-10-01 | ||
| 2015-10-01 holding as of filing | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.69 exercise price | 2015-10-01 | ||
| 2015-10-01 holding as of filing | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.64 exercise price | 2015-10-01 | ||
| 2015-10-01 holding as of filing | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.79 exercise price | 2015-10-01 | ||
| 2015-10-01 holding as of filing | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $27.43 exercise price | 2015-10-01 | ||
| 2015-10-01 holding as of filing | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $35.96 exercise price | 2015-10-01 | ||
| 2015-10-01 holding as of filing | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $52.85 exercise price | 2015-10-01 | ||
| 2015-10-01 holding as of filing | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $60.53 exercise price | 2015-10-01 | ||
| 2015-09-30 | Yang Tseli Lily Officer (VP, Finance and Accounting) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,388 33,388 owned after | $42.50 exercise price | 2015-10-01 | |
| 2015-09-30 | Templeman Thomas Officer (SVP, Pharmaceutical Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,440 45,440 owned after | $42.50 exercise price | 2015-10-01 | |
| 2015-09-30 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,380 2,380 owned after | $42.50 exercise price | 2015-10-01 | |
| 2015-09-25 | Machado Clarence Patrick Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −71,980 0 owned after | $4.69 exercise price | 2015-09-28 | |
| 2015-06-16 | YARNO WENDY L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,142 3,142 owned after | $110.90 exercise price | 2015-06-18 | |
| 2015-06-16 | VERNON W ANTHONY Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,142 3,142 owned after | $110.90 exercise price | 2015-06-18 | |
| 2015-06-16 | Svoronos Dawn Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,142 3,142 owned after | $110.90 exercise price | 2015-06-18 | |
| 2015-06-16 | Machado Clarence Patrick Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,142 3,142 owned after | $110.90 exercise price | 2015-06-18 | |
| 2015-06-16 | FALBERG KATHRYN E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,142 3,142 owned after | $110.90 exercise price | 2015-06-18 | |
| 2015-06-16 | BLICKENSTAFF KIM D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,142 3,142 owned after | $110.90 exercise price | 2015-06-18 | |
| 2015-06-04 | Machado Clarence Patrick Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,000 35,990 owned after | $9.39 exercise price | 2015-06-08 | |
| 2015-06-01 | Powell Andrew Kenneth William Officer (SVP, General Counsel & Crp Sec) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,430 20,430 owned after | $128.33 exercise price | 2015-06-02 | |
| 2015-04-15 | Bierly Rick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 28,023 owned after | $58.10 exercise price | 2015-04-16 | |
| 2015-03-02 | Rhodes Jennifer J Officer (GC & Corporate Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 38,000 owned after | $47.48 exercise price | 2015-03-02 | |
| 2015-02-26 | Rhodes Jennifer J Officer (GC & Corporate Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 40,000 owned after | $47.48 exercise price | 2015-02-27 | |
| 2015-02-17 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,000 31,000 owned after | $105.33 exercise price | 2015-02-18 | |
| 2015-02-17 | Rhodes Jennifer J Officer (GC & Corporate Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,000 19,000 owned after | $105.33 exercise price | 2015-02-18 | |
| 2015-02-17 | Hung David Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +114,000 114,000 owned after | $105.33 exercise price | 2015-02-18 | |
| 2015-02-17 | Bierly Rick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $105.33 exercise price | 2015-02-18 | |
| 2015-02-10 | Machado Clarence Patrick Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,000 71,990 owned after | $9.39 exercise price | 2015-02-12 | |
| 2015-01-27 | Machado Clarence Patrick Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,294 0 owned after | $10.59 exercise price | 2015-01-29 | |
| 2015-01-27 | Machado Clarence Patrick Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −28,706 107,990 owned after | $9.39 exercise price | 2015-01-29 |